Shanghai Fosun Pharmaceutical (Group) Co. Ltd. has filed an updated list of directors and their respective roles with the Hong Kong Stock Exchange. The Board is composed of 12 directors, including executive directors Mr. Chen Yuqing (chairman), Ms. Guan Xiaohui (co-chairman), Mr. Wen Deyong (vice chairman), Mr. Wang Kexin, and Mr. Liu Yi. Non-executive directors are Mr. Chen Qiyu and Mr. Pan Donghui, while independent non-executive directors include Mr. Yu Tze Shan Hailson, Mr. Wang Quandi, Mr. Chen Penghui, and Mr. Yang Yucheng. Ms. Yan Jia serves as the employee director. The Board oversees five specialized committees. Mr. Chen Yuqing chairs the Strategic Committee and sits on the Environmental, Social and Governance $(ESG)$ Committee. Ms. Guan Xiaohui and Mr. Wang Kexin are members of the Strategic Committee, with Ms. Guan also on the Nomination and ESG Committees. Mr. Chen Qiyu and Mr. Chen Penghui are members of the Strategic Committee; Mr. Pan Donghui serves on the Nomination and Remuneration and Appraisal Committees. Independent directors Mr. Wang Quandi, Mr. Chen Penghui, and Mr. Yang Yucheng chair the Nomination, Remuneration and Appraisal, and Audit Committees, respectively, with Mr. Yu Tze Shan Hailson chairing the ESG Committee. Committee memberships are distributed among the directors to provide diverse oversight across the company's governance structure.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251202-11940230), on December 02, 2025, and is solely responsible for the information contained therein.
Comments